Abstract
Accumulation of senescent fibroblasts, chronic inflammation, and collagen remodeling due to aging-related secretory phenotypes have been hypothesized to cause age-related skin aging, which results in wrinkles and loss of skin elasticity, thus compromising appearance attractiveness. However, the rejuvenating effects of removing senescent cells from the human skin and the efficacy of related therapeutic agents remain unclear. Here, we investigated the effects of fisetin, a potential anti-aging component found in various edible fruits and vegetables, on senescent human dermal fibroblasts (HDFs) and aging human skin. Senescence was induced in primary HDFs using long-term passaging and treatment with ionizing radiation, and cell viability was assessed after treatment with fisetin and a control component. A mouse/human chimeric model was established by subcutaneously transplanting whole skin grafts from aged individuals into nude mice, which were treated intraperitoneally with fisetin or control a component for 30 d. Skin samples were obtained and subjected to senescence-associated-beta-galactosidase staining; the extent of aging was evaluated using western blotting, reverse transcription-quantitative PCR, and histological analysis. Fisetin selectively eliminated senescent dermal fibroblasts in both senescence-induced cellular models; this effect is attributable to cell death induction by caspases 3, 8, and 9-mediated endogenous and exogenous apoptosis. Fisetin-treated senescent human skin grafts showed increased collagen density and decreased senescence-associated secretory phenotypes (SASP), including matrix metalloproteinases and interleukins. No apparent adverse events were observed. Thus, fisetin could improve skin aging through selective removal of senescent dermal fibroblasts and SASP inhibition, indicating its potential as an effective novel therapeutic agent for combating skin aging.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll T, Capper D, Pritchard C, Inman GJ, Longerich T, Sansom OJ, Benitah SA, Zender L, Gil J (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15:978–990. https://doi.org/10.1038/ncb2784
Aral K, Aral CA, Kapila Y (2019) The role of caspase-8, caspase-9, and apoptosis inducing factor in periodontal disease. J Periodontol 90:288–294. https://doi.org/10.1002/JPER.17-0716
Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A, Khazaie K, Miller JD, van Deursen JM (2016) Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530:184–189. https://doi.org/10.1038/nature16932
Charkhat Gorgich EA, Heidari Z, Mahmoudzadeh-Sagheb H (2017) P16ink4a subcellular expression patterns in colorectal adenocarcinoma, Adenoma and non-neoplastic tissue samples. Asian Pac J Cancer Prev 18:3049–3054. https://doi.org/10.22034/APJCP.2017.18.11.3049
Chirumbolo S, Bertossi D, Magistretti P (2023) Insights on the role of L-lactate as a signaling molecule in skin aging. Biogerontology. https://doi.org/10.1007/s10522-023-10018-1
Chung CL, Lawrence I, Hoffman M, Elgindi D, Nadhan K, Potnis M, Jin A, Sershon C, Binnebose R, Lorenzini A, Sell C (2019) Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial. Geroscience 41:861–869. https://doi.org/10.1007/s11357-019-00113-y
Coppé JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99–118. https://doi.org/10.1146/annurev-pathol-121808-102144
Elsallabi O, Patruno A, Pesce M, Cataldi A, Carradori S, Gallorini M (2022) Fisetin as a senotherapeutic agent: biopharmaceutical properties and crosstalk between cell senescence and neuroprotection. Molecules 27:738. https://doi.org/10.3390/molecules27030738
Farsad-Naeimi A, Alizadeh M, Esfahani A, Aminabad ED (2018) Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients. Food Funct 9:2025–2031. https://doi.org/10.1039/c7fo01898c
Farsam V, Basu A, Gatzka M, Treiber N, Schneider LA, Mulaw MA, Lucas T, Kochanek S, Dummer R, Levesque MP, Wlaschek M, Scharffetter-Kochanek K (2016) Senescent fibroblast-derived chemerin promotes squamous cell carcinoma migration. Oncotarget 7:83554–83569. https://doi.org/10.18632/oncotarget.13446
Grynkiewicz G, Demchuk OM (2019) New perspectives for fisetin. Front Chem 7:697. https://doi.org/10.3389/fchem.2019.00697
Janson D, Saintigny G, Mahé C, El Ghalbzouri A (2013) Papillary fibroblasts differentiate into reticular fibroblasts after prolonged in vitro culture. Exp Dermatol 22:48–53. https://doi.org/10.1111/exd.12069
Johmura Y, Yamanaka T, Omori S, Wang TW, Sugiura Y, Matsumoto M, Suzuki N, Kumamoto S, Yamaguchi K, Hatakeyama S, Takami T, Yamaguchi R, Shimizu E, Ikeda K, Okahashi N, Mikawa R, Suematsu M, Arita M, Sugimoto M, Nakayama KI, Furukawa Y, Imoto S, Nakanishi M (2021) Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science 371:265–270. https://doi.org/10.1126/science.abb5916
Kim OY, Chae JS, Paik JK, Seo HS, Jang Y, Cavaillon JM, Lee JH (2012) Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age (Dordr) 34:415–425. https://doi.org/10.1007/s11357-011-9244-2
Kim H, Jang J, Song MJ, Kim G, Park CH, Lee DH, Lee SH, Chung JH (2022a) Attenuation of intrinsic ageing of the skin via elimination of senescent dermal fibroblasts with senolytic drugs. J Eur Acad Dermatol Venereol 36:1125–1135. https://doi.org/10.1111/jdv.18051
Kim H, Jang J, Song MJ, Park CH, Lee DH, Lee SH, Chung JH (2022b) Inhibition of matrix metalloproteinase expression by selective clearing of senescent dermal fibroblasts attenuates ultraviolet-induced photoaging. Biomed Pharmacother 150:113034. https://doi.org/10.1016/j.biopha.2022b.113034
Kirkland JL, Tchkonia T (2020) Senolytic drugs: from discovery to translation. J Intern Med 288:518–536. https://doi.org/10.1111/joim.13141
Liakou E, Mavrogonatou E, Pratsinis H, Rizou S, Evangelou K, Panagiotou PN, Karamanos NK, Gorgoulis VG, Kletsas D (2016) Ionizing radiation-mediated premature senescence and paracrine interactions with cancer cells enhance the expression of syndecan 1 in human breast stromal fibroblasts: the role of TGF-β. Aging 8:1650–1669. https://doi.org/10.18632/aging.100989
Maher P (2021) Preventing and treating neurological Disorders with the Flavonol Fisetin. Brain Plast 6:155–166. https://doi.org/10.3233/BPL-200104
Martel J, Ojcius DM, Wu CY, Peng HH, Voisin L, Perfettini JL, Ko YF, Young JD (2020) Emerging use of senolytics and senomorphics against aging and chronic diseases. Med Res Rev 40:2114–2131. https://doi.org/10.1002/med.21702
Mine S, Fortunel NO, Pageon H, Asselineau D (2008) Aging alters functionally human dermal papillary fibroblasts but not reticular fibroblasts: a new view of skin morphogenesis and aging. PLoS ONE 3:e4066. https://doi.org/10.1371/journal.pone.0004066
Mohamad Anuar NN, Nor Hisam NS, Liew SL, Ugusman A (2020) Clinical review: navitoclax as a pro-apoptotic and anti-fibrotic agent. Front Pharmacol 11:564108. https://doi.org/10.3389/fphar.2020.564108
Ravula AR, Teegala SB, Kalakotla S, Pasangulapati JP, Perumal V, Boyina HK (2021) Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: an updated review. Eur J Pharmacol 910:174492. https://doi.org/10.1016/j.ejphar.2021.174492
Schneider LA, Raizner K, Wlaschek M, Brenneisen P, Gethöffer K, Scharffetter-Kochanek K (2017) UVA-1 exposure in vivo leads to an IL-6 surge within the skin. Exp Dermatol 26:830–832. https://doi.org/10.1111/exd.13286
Shin JW, Kwon SH, Choi JY, Na JI, Huh CH, Choi HR, Park KC (2019) Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci 20:2126. https://doi.org/10.3390/ijms20092126
Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, Weiss JM, Wlaschek M, Sunderkötter C, Scharffetter-Kochanek K (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 121:985–997. https://doi.org/10.1172/JCI44490
Soto-Gamez A, Demaria M (2017) Therapeutic interventions for aging: the case of cellular senescence. Drug Discov Today 22:786–795. https://doi.org/10.1016/j.drudis.2017.01.004
Spallarossa P, Altieri P, Barisione C, Passalacqua M, Aloi C, Fugazza G, Frassoni F, Podestà M, Canepa M, Ghigliotti G, Brunelli C (2010) p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells. PLoS ONE 5:e15583. https://doi.org/10.1371/journal.pone.0015583
Takaya K, Ishii T, Asou T, Kishi K (2022) Glutaminase inhibitors rejuvenate human skin via clearance of senescent cells: a study using a mouse/human chimeric model. Aging 14:8914–8926. https://doi.org/10.18632/aging.204391
Takaya K, Ishii T, Asou T, Kishi K (2023) Navitoclax (ABT-263) rejuvenates human skin by eliminating senescent dermal fibroblasts in a mouse/human chimeric model. Rejuvenation Res 26:9–20. https://doi.org/10.1089/rej.2022.0048
Tavsan Z, Kayali HA (2019) Flavonoids showed anticancer effects on the ovarian cancer cells: involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomed Pharmacother 116:109004. https://doi.org/10.1016/j.biopha.2019.109004
Waaijer ME, Parish WE, Strongitharm BH, van Heemst D, Slagboom PE, de Craen AJ, Sedivy JM, Westendorp RG, Gunn DA, Maier AB (2012) The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell 11:722–725. https://doi.org/10.1111/j.1474-9726.2012.00837.x
Waldera Lupa DM, Kalfalah F, Safferling K, Boukamp P, Poschmann G, Volpi E, Götz-Rösch C, Bernerd F, Haag L, Huebenthal U, Fritsche E, Boege F, Grabe N, Tigges J, Stühler K, Krutmann J (2015) Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. J Invest Dermatol 135:1954–1968. https://doi.org/10.1038/jid.2015.120
Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, von Zglinicki T (2009) DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8:311–323. https://doi.org/10.1111/j.1474-9726.2009.00481.x
Wedel S, Martic I, Hrapovic N, Fabre S, Madreiter-Sokolowski CT, Haller T, Pierer G, Ploner C, Jansen-Dürr P, Cavinato M (2020) tBHP treatment as a model for cellular senescence and pollution-induced skin aging. Mech Ageing Dev 190:111318. https://doi.org/10.1016/j.mad.2020.111318
Wlaschek M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharffetter-Kochanek K (1994) UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 59:550–556. https://doi.org/10.1111/j.1751-1097.1992.tb04222.x
Wlaschek M, Maity P, Makrantonaki E, Scharffetter-Kochanek K (2021) Connective tissue and fibroblast senescence in skin aging. J Invest Dermatol 141:985–992. https://doi.org/10.1016/j.jid.2020.11.010
Youns M, Abdel Halim Hegazy W (2017) The natural flavonoid fisetin inhibits cellular proliferation of hepatic, colorectal, and pancreatic cancer cells through modulation of multiple signaling pathways. PLoS ONE 12:e0169335. https://doi.org/10.1371/journal.pone.0169335
Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, Xu M, Ling YY, Melos KI, Pirtskhalava T, Inman CL, McGuckian C, Wade EA, Kato JI, Grassi D, Wentworth M, Burd CE, Arriaga EA, Ladiges WL, Tchkonia T, Kirkland JL, Robbins PD, Niedernhofer LJ (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18–28. https://doi.org/10.1016/j.ebiom.2018.09.015
Acknowledgements
The authors thank the laboratory members for their technical assistance with the experiments.
Funding
This research was funded by JSPS KAKENHI (grant number: JP 22K19589).
Author information
Authors and Affiliations
Contributions
Conceptualization, KT, TA, KK; formal analysis, KT; investigation, KT; writing—original draft preparation, KT; supervision, TA and KK.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
The protocol for animal experiments was reviewed and approved by the Institutional Animal Care and Use Committee of Keio University School of Medicine (approval number: 13072-(2)). Human skin sampling complied with ethical guidelines for life science and medical research involving human subjects. All procedures involving human subjects were approved by the University Institutional Review Board (IRB No. 1101-116-353), and volunteers provided written informed consent.
Consent for publication
The funders had no role in the study design, collection, analyses, or interpretation of data, writing of the manuscript, or the decision to publish the results.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Takaya, K., Asou, T. & Kishi, K. Fisetin, a potential skin rejuvenation drug that eliminates senescent cells in the dermis. Biogerontology 25, 161–175 (2024). https://doi.org/10.1007/s10522-023-10064-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-023-10064-9